High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A

Rees, 1995, World distribution of factor V Leiden, Lancet, 346, 1133, 10.1016/S0140-6736(95)91803-5 Rosendaal, 1998, Geographic distribution of the 20210 G to A prothrombin mutation, J. Thromb. Haemost., 79, 706, 10.1055/s-0037-1615049 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85-1504-1508. Poort, 1996, A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, 88, 3698, 10.1182/blood.V88.10.3698.bloodjournal88103698 Ehrenforth, 2003, Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A, J. Thromb. Haemost., 2, 430, 10.1111/j.1538-7836.2004.00606.x Emmerich, 2001, Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism, J. Thromb. Haemost., 86, 809, 10.1055/s-0037-1616136 Folsom, 2002, A prospective study of venous thromboembolism in relation to factor V Leiden and related factors, Blood, 99, 2720, 10.1182/blood.V99.8.2720 The Procare Group, 2000, Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the Procare study, Blood Coagul. Fibrinolysis, 11, 511, 10.1097/00001721-200009000-00002 Lijfering, 2010, Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of Factor V Leiden and prothrombin G20210A, Circulation, 121, 1706, 10.1161/CIRCULATIONAHA.109.906347 Saemundsson, 2013, Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation, J. Thromb. Thrombolysis, 36, 324, 10.1007/s11239-012-0824-5 Perez Botero, 2016, Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study, Eur. J. Intern. Med., 30, 77, 10.1016/j.ejim.2016.02.023 Lim, 2016, Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals, Eur. J. Haematol., 97, 353, 10.1111/ejh.12738 Ledford, 2000, A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay, J. Mol. Diagn., 2, 97, 10.1016/S1525-1578(10)60623-X Weyant, 2014, A methodological comparison of Invader and Autogenomics INFINITI in factor-V Leiden and Prothrombin Gene Mutation testing, J. Clin. Diagn. Res., 2, 1 Bounameaux, 2000, Factor V Leiden paradox: risk of deep vein thrombosis but not of pulmonary embolism, Lancet, 356, 182, 10.1016/S0140-6736(00)02476-4